A review of stress ulcer prophylaxis

Journal of Pharmacy Practice

Volumn 15, Issue 2, 2002, Pages 147-157

  MacLaren, Robert ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Antacid; Critical care; Histamine receptor antagonist; Proton pump inhibitor; Sucralfate; Ulcer

Indexed keywords

ANTACID AGENT; CIMETIDINE; CYTOCHROME P450 ISOENZYME; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; NIZATIDINE; OMEPRAZOLE; PANTOPRAZOLE; PIRENZEPINE; PLACEBO; PROTON PUMP INHIBITOR; RABEPRAZOLE; RANITIDINE; SUCRALFATE;

ANEMIA; ARTIFICIAL VENTILATION; BLOOD CLOTTING DISORDER; CLINICAL TRIAL; COST CONTROL; CRITICAL ILLNESS; DRUG CHOICE; DRUG COST; DRUG EFFICACY; DRUG MECHANISM; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL MUCOSA; HEAD INJURY; HEMATEMESIS; HEMATOCHEZIA; HUMAN; HYPOTENSION; ISCHEMIA; KIDNEY DYSFUNCTION; KIDNEY TRANSPLANTATION; LIVER DYSFUNCTION; LIVER TRANSPLANTATION; MELENA; META ANALYSIS; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; SHOCK; SPINAL CORD INJURY; STRESS ULCER; TACHYCARDIA; THERMAL INJURY;

EID: 0036085703     PISSN: 08971900     EISSN: None     Source Type: Journal    
DOI: 10.1106/EAD9-P8RX-D7J7     Document Type: Review

References (46)

1. Changing perspectives of stress ulcer prophylaxis
2. ASHP therapeutic guidelines on stress ulcer prophylaxis
3. GI complications in patients receiving mechanical ventilation
4. Natural history and surgical dilemma of stress gastric bleeding
5. Prophylaxis for stress-related gastrointestinal hemorrhage: A cost effectiveness analysis
6. Prophylactic therapy for stress ulcer bleeding: A reappraisal
7. Prevalence of Helicobacter pylori infection in stress-induced gastric mucosal injury
8. Helicobacterpylori infection: A risk factor for upper gastrointestinal bleeding after cardiac surgery
9. The virtual absence of stressulceration related bleeding in ICU patients receiving prolonged mechanical ventilation without any prophylaxis: A prospective, cohort study
10. Current guidelines on stress ulcer prophylaxis
11. Nosocomial pneumonia and the role of gastric pH: A meta-analysis
12. Risk factors for clinically important upper gastrointestinal bleeding in patients requiring mechanical ventilation
13. Risk factors for gastrointestinal bleeding in critically ill patients
14. Prospective study of clinical bleeding in intensive care unit patients
15. Gastrointestinal bleeding in trauma patients: Incidence and risk factors
16. Prospective evaluation of the risk of upper gastrointestinal bleeding after admission to a medical intensive care unit
17. Impact of multiple risk factors and ranitidine prophylaxis on the development of stressrelated upper gastrointestinal bleeding: A prospective, multicenter, double-blind, randomized study
18. Enteral nutrition for stress ulcer prophylaxis
19. National survey of stress ulcer prophylaxis
20. Comparison of the effect of intermittent administration and continuous infusion of famotidine on gastric pH in critically ill patients: Results of a prospective, randomized, crossover study
21. Pharmacodynamic modeling of the acid inhibitory effect of ranitidine in patients in an intensive care unit during prolonged dosing: Characterization of tolerance
22. Twenty-four-hour intragastric pH: Tolerance within 5 days of continuous ranitidine administration
23. Review article: The pharmacological inhibition of gastric acid secretion - Tolerance and rebound
24. The role of H2-receptor antagonists in the pathogenesis of nosocomial pneumonia in mechanically ventilated patients
25. Prophylaxis of upper gastrointestinal bleeding in intensive care units: A meta-analysis
26. Stress ulcer prophylaxis in the critically ill: A meta analysis
27. Histamine-2-receptor antagonists and antacids in the critically ill population: Stress ulceration versus nosocomial pneumonia
28. Stress ulcer prophylaxis in critically ill. Resolving discordant meta-analyses
29. 2-antagonists for stress ulcer prophylaxis: A meta-analysis on efficacy and pneumonia rate
30. Prophylaxis of stress ulcer bleeding: A meta-analysis
31. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding patients requiring mechanical ventilation
32. Effect of lansoprazole suspension versus continuous ranitidine on gastric pH of mechanically ventilated intensive care unit patients
33. A prospective study of simplified omeprazole suspension for the prophylaxis of stress-related mucosal damage
34. A prospective study of omeprazole suspension to prevent clinically significant gastrointestinal bleeding from stress ulcers in mechanically ventilated trauma patients
35. Comparison of omeprazole and ranitidine for stress ulcer prophylaxis
36. A multicenter, prospective, randomized clinical trial of continuous I.V. ranitidine vs. omeprazole suspension in the prophylaxis of stress ulcer prophylaxis
37. A comparison of lansoprazole and sucralfate for the prophylaxis of stress-related mucosal damage in critically ill patients
38. Inhibitory effects of intravenous lansoprazole on gastric acid hypersecretion in patients with postoperative stress
39. The potential clinical role of intravenous omeprazole
40. Nasogastric omeprazole: Effects on gastric pH in critically ill patients
41. Optimal therapy for stress gastritis
42. Pharmacoeconomic analysis of stress ulcer prophylaxis for critically ill patients
43. Stress ulcer prophylaxis may not be for everyone
44. Impact of stress ulcer prophylaxis guidelines on drug costs and frequency of major gastrointestinal bleeding
45. Stress ulcer prophylaxis in medical ICU patients: Annual utilization in relation to the incidence of endoscopically proven stress ulceration
46. Impacting cost and appropriateness of stress ulcer prophylaxis at a university medical center